The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 28, 2024

Filed:

Apr. 21, 2017
Applicants:

Genethon, Evry, FR;

Inserm (Institut National DE LA Santé ET DE LA Recherche Médicale), Paris, FR;

Universite D'evry Val D'essonne, Evry, FR;

Inventor:

Anne Galy, Fontainebleau, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/63 (2006.01); A61K 35/17 (2015.01); A61K 35/76 (2015.01); C07H 21/04 (2006.01); C07K 14/005 (2006.01); C12N 5/0781 (2010.01); C12N 15/85 (2006.01); C12N 15/86 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 35/17 (2013.01); A61K 35/76 (2013.01); C07K 14/005 (2013.01); C12N 5/0635 (2013.01); A61K 48/00 (2013.01); C12N 2740/10022 (2013.01); C12N 2740/16022 (2013.01); C12N 2740/16043 (2013.01); C12N 2740/16052 (2013.01);
Abstract

The present invention relates to a method for obtaining stable pseudotyped lentiviral particles including a heterologous gene of interest, comprising the following steps: a) transfecting at least one plasmid in appropriate cell lines, wherein said at least one plasmid comprises the gene of interest, the rev. gag and pol genes, and a sequence coding for an ERV syncytin, wherein the rev, gag and pol genes are retroviral genes; b) incubating the transfected cells obtained in a), so that they produce the stable pseudotyped lentiviral particles in the supernatant; and c) harvesting and concentrating the stable lentiviral particles obtained in b). The present invention also relates to a method to transduce immune cells using lentiviral vectors pseudotyped with an ERV syncytin glycoprotein. The method can be performed on non-stimulated blood cells or on cells stimulated briefly with IL7, and the cells can be expanded. The stable pseudotyped lentiviral particles obtained are particularly useful in gene therapy.


Find Patent Forward Citations

Loading…